Home About Browse Policies Statistics

Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial

(DATO')(DR.), CHE KHALID BIN HAJI YUSOFF (2002) Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet, 22 (1).

Full text not available from this repository.

Metadata

Item Type: Article
Journal or Publication Title: Lancet
PRISMA ID: 3601
URI: http://oarr.uitm.edu.my/id/eprint/989

Actions (login required)

View Item
View Item

Citation